Denmark
LEO Pharma and ICON partner for clinical trial execution in dermatology
The collaboration is expected to provide access to innovative clinical trials as well as help to launch new medicines.
Hemab doses first patient in Phase I/II trial of antibody for Glanzmann
Bavarian Nordic completes subject enrolment in RSV vaccine trial
Zealand Pharma reports data from Phase III short bowel syndrome trial
Bavarian Nordic reports positive data from Phase II Covid-19 booster trial
Leo Pharma partners with Veeva Systems to digitalise clinical trials
Bavarian Nordic starts Phase II Covid-19 booster vaccine study
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
